New study finds maternal vaccine and monoclonal antibody effective against RSV in infants Post author: Post published:January 10, 2024 Post category:uncategorized The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy. You Might Also Like Does immediate parent-infant skin-to-skin contact improve interaction in very preterm babies at 4 months? December 4, 2023 New hope for GI cancers: Review analyzes molecular targets and treatment advancements June 18, 2024 Scientists discover hidden intricacies of sperm motility October 25, 2023
Does immediate parent-infant skin-to-skin contact improve interaction in very preterm babies at 4 months? December 4, 2023